Clinical Trial Update: A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

View source ↗

Summary

This clinical trial is currently recruiting to evaluate the safety and effectiveness of YUTIQ 0.18 mg intravitreal implant for chronic non-infectious uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• YUTIQ (fluocinolone acetonide)

Snippet

Sponsor: Tianjin Medical University | Conditions: Uveitis, YUTIQ | Status: RECRUITING